Stryker Corp Stock Price, News & Analysis

Stryker reported a robust financial performance for Q2 2021, with net sales of $4.3 billion, a significant increase of 55.4% from 2020 and 17.6% from 2019. Organic net sales rose 42.9% year-over-year. Key segments showed impressive growth: Orthopaedics net sales surged 82.3%, MedSurg increased 32.3%, and Neurotechnology and Spine rose 66.9%. Adjusted EPS reached $2.25, up from $0.64 in the prior year. Stryker raised its 2021 guidance, anticipating organic growth of 9% to 10% and adjusted EPS of $9.25 to $9.40, amidst ongoing recovery from the pandemic.

Stryker (NYSE:SYK) will host a conference call on July 27, 2021, at 4:30 p.m. ET to discuss its operating results for the quarter ending June 30, 2021. The final operating results will be released at 4:05 p.m. on the same day. Participants can join the call via phone or through a webcast available on Stryker's website. A recording will be available from 8:00 p.m. on July 27 until August 3, 2021. For more details, visit www.stryker.com.

Stryker (NYSE:SYK) has declared a quarterly dividend of $0.63 per share, payable on July 30, 2021, for shareholders of record by June 30, 2021. This represents a significant 9.6% increase compared to the previous year, while remaining unchanged from the last quarter. As one of the leading medical technology companies, Stryker is committed to enhancing healthcare outcomes through its innovative products across Orthopaedics, Medical and Surgical, and Neurotechnology sectors.

Stryker reported Q1 2021 results indicating 10.2% increase in net sales to $4.0 billion compared to 2020, despite ongoing impacts from COVID-19. Adjusted EPS rose 4.9% to $1.93, while reported EPS fell 39.2% to $0.79. Orthopaedics saw a 21.4% growth in net sales, but MedSurg remained flat. The company anticipates 8%-10% organic net sales growth for 2021 and adjusted EPS between $9.05 to $9.30, factoring in currency impacts. The integration of Wright Medical is on track.

Stryker (NYSE:SYK) will participate in the Bank of America Securities 2021 Virtual Health Care Conference on May 11, 2021, at 4:15 p.m. ET. Key representatives include Spencer Stiles, Group President, Orthopaedics & Spine; Robert Cohen, President, Digital, Robotics and Enabling Technologies; and Preston Wells, Vice President, Investor Relations. A webcast of the presentation will be available on Stryker's website, where it will also be archived. Stryker is a leader in medical technology, focusing on improving healthcare outcomes through innovative products and services.

Stryker (NYSE:SYK) will host a conference call on April 27, 2021, at 4:30 p.m. ET to discuss its operating results for Q1 2021, ending March 31. The final results will be available at 4:05 p.m. ET on the same day. Participants can join by calling (877) 702-4565 domestically or (647) 689-5532 internationally, using conference ID 8988724. The call will also be streamed live on Stryker's website and archived for later access. A recording will be available from 8 p.m. ET on April 27 until May 4, 2021. More details can be found at www.stryker.com.

Stryker (NYSE:SYK) has announced that its 2021 Annual Meeting of Shareholders will take place virtually on May 5, 2021, at 2:00 PM ET, due to COVID-19 health concerns. Shareholders can access the meeting via a webcast on the company's Investor Relations page or join by phone using the provided conference ID. A recording of the meeting will be available from May 6, 2021. Stryker is recognized as a leading medical technology company focused on innovative products and services across various medical fields, improving healthcare outcomes for patients and hospitals.

Stryker (NYSE:SYK) will participate in the 41st Annual Cowen Health Care Conference on March 2, 2021. The virtual presentation is scheduled for 10:30 a.m. Eastern Time and will feature Preston Wells, Vice President of Investor Relations, and Andy Pierce, Group President of MedSurg & Neurotechnology.

A webcast and replay of the presentation will be accessible on Stryker's website at www.stryker.com.

Stryker is a leading medical technology company focused on improving healthcare outcomes.

Stryker reported a 3.2% increase in Q4 2020 net sales to $4.3 billion but faced a 3.6% decline for the full year, totaling $14.4 billion. Organic net sales dropped 1.1% in Q4 and 4.8% annually, impacted by COVID-19. Adjusted EPS rose 12.9% to $2.81 for Q4, but decreased 10% to $7.43 for the year. The company anticipates an 8-10% organic growth in 2021 and adjusted EPS between $8.80 and $9.20. Challenges include persistent pricing pressures and pandemic effects, but optimism remains for recovery in elective procedures.